DRIVE - Brand-specific influenza vaccine effectiveness in Europe, season 2018/19 (DRIVE 2018/19)First published 20/05/2019 Last updated 03/05/2021 EU PAS number: EUPAS29817StudyFinalised
P95 Clinical and Epidemiology ServicesBelgiumColombiaNetherlandsSouth AfricaThailandUnited States First published: 07/11/2022Last updated 21/02/2025 InstitutionLaboratory/Research/Testing facilityNon-Pharmaceutical companyENCePP partner
Development of Robust and Innovative Vaccine Effectiveness (DRIVE)BelgiumEuropean UnionFinlandFranceItalyNetherlandsSpainUnited Kingdom First published: 22/05/2019Last updated 20/08/2024 Network